Analysts think CLGN stock price could increase by 125%
Jun 14, 2024, 6:29 AM
0.20%
What does CLGN do
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company specializing in products and technologies for tissue regeneration and organ production. Their technology utilizes plant-based type I recombinant human collagen (rhCollagen).
3 analysts think CLGN stock price will increase by 124.85%. The current median analyst target is $11.22 compared to a current stock price of $4.99. The lowest analysts target is $11.11 and the highest analyst target is $11.55.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.